Yumiko Kagawa Selected Research

Paratuberculosis (Johne's Disease)

1/2018	Prostaglandin E2 Induction Suppresses the Th1 Immune Responses in Cattle with Johne's Disease.
1/2016	Bovine Immunoinhibitory Receptors Contribute to Suppression of Mycobacterium avium subsp. paratuberculosis-Specific T-Cell Responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yumiko Kagawa Research Topics

Disease

17	Neoplasms (Cancer) 01/2024 - 07/2007
6	Lymphoma (Lymphomas) 11/2022 - 09/2011
4	Melanoma (Melanoma, Malignant) 01/2023 - 01/2016
3	Polyps 10/2020 - 03/2017
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2017 - 10/2016
3	Enteritis 09/2014 - 07/2013
2	Anemia 07/2023 - 01/2023
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 07/2019
2	Lymphatic Metastasis 01/2023 - 12/2021
2	Inflammation (Inflammations) 01/2023 - 09/2014
2	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2017
2	Histiocytic Sarcoma 11/2021 - 01/2011
2	Plasmacytoma 09/2019 - 09/2011
2	Paratuberculosis (Johne's Disease) 01/2018 - 01/2016
2	Infections 12/2013 - 05/2008
1	Pulmonary Atelectasis 01/2024
1	Astrocytoma (Pilocytic Astrocytoma) 01/2024
1	Pneumothorax 01/2024
1	Ependymoma 01/2024
1	Subependymal Glioma (Subependymoma) 01/2024
1	Hemangiosarcoma (Angiosarcoma) 11/2023
1	Peritonitis 07/2023
1	Disease Progression 07/2023
1	Persistent Infection 07/2023
1	Listeriosis (Listeria Infection) 07/2023
1	Adenocarcinoma 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Osteogenesis Imperfecta (Lobstein Disease) 05/2022
1	Hypoglycemia (Reactive Hypoglycemia) 03/2022
1	Osteosarcoma (Osteogenic Sarcoma) 12/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2019
1	Pancreatitis 10/2018
1	Body Weight (Weight, Body) 10/2018
1	Lung Neoplasms (Lung Cancer) 12/2017
1	Esophageal Neoplasms (Esophageal Cancer) 12/2017
1	Mesothelioma 12/2017
1	Brain Neoplasms (Brain Tumor) 12/2017
1	Mouth Neoplasms (Oral Cancer) 12/2017
1	Squamous Cell Carcinoma of Head and Neck 12/2017
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2017
1	Myasthenia Gravis 01/2017

Drug/Important Bio-Agent (IBA)

7	LigandsIBA 01/2023 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 06/2019 - 07/2007
5	AntibodiesIBA 01/2023 - 10/2007
4	Monoclonal AntibodiesIBA 07/2023 - 12/2016
4	ParaffinIBA 11/2022 - 01/2012
3	Prednisolone (Predate)FDA LinkGeneric 07/2023 - 10/2018
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2016
3	Formaldehyde (Formol)FDA Link 11/2022 - 09/2015
3	AntigensIBA 01/2016 - 10/2007
2	Complementary DNA (cDNA)IBA 07/2023 - 11/2015
2	Potassium Iodide (Pima)FDA Link 07/2023 - 01/2023
2	Immune Checkpoint ProteinsIBA 01/2023 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 09/2019
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 11/2022 - 09/2011
2	CollagenIBA 05/2022 - 01/2013
2	Glycoproteins (Glycoprotein)IBA 10/2020 - 12/2017
2	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2017 - 08/2013
2	HLA-DR Antigens (HLA-DR)IBA 05/2016 - 01/2011
2	Messenger RNA (mRNA)IBA 04/2015 - 08/2013
2	Cell Adhesion MoleculesIBA 09/2014 - 08/2013
2	Indicators and Reagents (Reagents)IBA 01/2012 - 05/2008
2	DesminIBA 10/2007 - 07/2007
2	Inhibins (Inhibin)IBA 10/2007 - 07/2007
2	placental alkaline phosphataseIBA 10/2007 - 07/2007
1	TubulinIBA 01/2024
1	SynaptophysinIBA 01/2024
1	NestinIBA 01/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 07/2023
1	Therapeutic UsesIBA 07/2023
1	Thyroglobulin FDA Link 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2023
1	InterferonsIBA 01/2023
1	ProteomeIBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2022
1	Insulin (Novolin)FDA Link 03/2022
1	toceranib phosphateIBA 10/2021
1	Leucine (L-Leucine)FDA Link 10/2020
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 09/2019
1	IgKIBA 09/2019
1	Immunoglobulins (Immunoglobulin)IBA 09/2019
1	Amino Acids FDA Link 07/2019
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Tuberculin (PPD)IBA 01/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	C-Type Lectins (C-Type Lectin)IBA 12/2017
1	Cholinergic ReceptorsIBA 01/2017

Therapy/Procedure

7	Therapeutics 06/2023 - 07/2013
5	Immunotherapy 06/2023 - 01/2016
2	Molecular Targeted Therapy 12/2017 - 05/2016
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2024
1	Splenectomy 01/2023
1	Surgical Amputation (Amputations) 12/2021
1	Radiotherapy 11/2021
1	Aftercare (After-Treatment) 10/2018